Go to Page # Page of 65

Indolent Non-Hodgkin's Lymphomas: Issues in Clinical Practice

 Michael L. Grossbard, MD
Description: There were 65,980 new cases of Non-Hodgkin's Lymphomas in U.S. in 2009, and 19,500 deaths from NHL in 2009. 30-40% of cases of NHL are “low grade” or “indolent”; 22% follicular. The median survival historically is 7-9 years; with new therapies alter survival (12-14 yrs). Little is known about etiology for indolent NHL. Increased incidence in autoimmune disease including Sjogren’s, Hashimoto’s, RA. Treatments and new approaches are examined.
Views: 2720
Domain: Medical
Category: Therapy
Indolent NHL: Issues In Clinical Practice

Michael L. Grossbard, MD St. Luke's-Roosevelt Hospital Center Beth Israel Medical Center

Indolent NHL
� 65,980 new cases NHL in U.S. in 2009 � 19,500 deaths from NHL in 2009 � 30-40% of cases of NHL are "low grade" or "indolent"; 22% follicular � Median survival historically 7-9 years � New the ... See more

Recent Presentations

Raphael Procher
18 June, 2019
Laura Collie PhD
17 June, 2019
Shuyang Zhang MD
14 June, 2019